Oligomeric states of the Shigella translocator protein IpaB provide structural insights into formation of the type III secretion translocon-Reference-Cited by-同舟云学术

Oligomeric states of the Shigella translocator protein IpaB provide structural insights into formation of the type III secretion translocon

Published:2013-03-18 Issue:5 Volume:22 Page:614-627
ISSN:0961-8368
Container-title:Protein Science
language:en
Short-container-title:Protein Science

Author:

Dickenson Nicholas E.,Choudhari Shyamal P.,Adam Philip R.,Kramer Ryan M.,Joshi Sangeeta B.,Middaugh C. Russell,Picking Wendy L.,Picking William D.

Funder

NIH

OCAST

Publisher

Wiley

Subject

Molecular Biology,Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pro.2245/fullpdf

Reference37 articles.

1. Inoculum size in shigellosis and implications for expected mode of transmission;DuPont;J Infect Dis.,1989

2. Global burden of Shigella infections: implications for vaccine development and implementation of control strategies;Kotloff;Bull World Health Organ.,1999

3. Molecular pathogenesis of Shigella spp.: controlling host cell signaling, invasion, and death by type III secretion;Schroeder;Clin Microbiol Rev.,2008

4. The type III secretion injectisome, a complex nanomachine for intracellular “toxin” delivery;Cornelis;Biol Chem.,2010

5. Structure and composition of the Shigella flexneri “needle complex,” a part of its type III secreton;Blocker;Mol Microbiol.,2001

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathogenicity and virulence of Shigella sonnei : A highly drug-resistant pathogen of increasing prevalence;Virulence;2023-11-23

2. A Novel Shigella O-Polysaccharide–IpaB Conjugate Vaccine Elicits Robust Antibody Responses and Confers Protection against Multiple Shigella Serotypes;mSphere;2023-06-22

3. PopB-PcrV Interactions Are Essential for Pore Formation in the Pseudomonas aeruginosa Type III Secretion System Translocon;mBio;2022-10-26

4. From Concept to Clinical Product: A Brief History of the Novel Shigella Invaplex Vaccine’s Refinement and Evolution;Vaccines;2022-04-01

5. Phosphomimetic Tyrosine Mutations in Spa47 Inhibit Type Three Secretion ATPase Activity and Shigella Virulence Phenotype;Pathogens;2022-02-03